[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Exosome Diagnostic and Therapeutic Market Report 2017

October 2017 | 107 pages | ID: UFCF53B52ABWEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Exosome Diagnostic and Therapeutic market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Exosome Diagnostic and Therapeutic in these regions, from 2012 to 2022 (forecast).
United States Exosome Diagnostic and Therapeutic market competition by top manufacturers/players, with Exosome Diagnostic and Therapeutic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Aethlon Medical
  • Exosome Diagnostics
  • NanoSomix
  • Thermo Fisher Scientific
  • Malvern Instruments
  • System Biosciences
  • NX Pharmagen
  • Sistemic
  • Capricor Therapeutics
  • Exiqon
  • 101BIO
  • AMS Biotechnology Limited
  • Therapeutic Solutions International
  • ReNeuron Group
  • Immune Therapy Holdings
  • ExoCyte Therapeutics
  • Cell Guidance Systems
  • BioRegenerative Sciences
  • Evomic Science
  • Norgen Biotek
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Instrument
  • Reagent
  • Software
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Exosome Diagnostic and Therapeutic for each application, including
  • Cancer Institute
  • Hospital
  • Diagnostic Center
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Exosome Diagnostic and Therapeutic Market Report 2017

1 EXOSOME DIAGNOSTIC AND THERAPEUTIC OVERVIEW

1.1 Product Overview and Scope of Exosome Diagnostic and Therapeutic
1.2 Classification of Exosome Diagnostic and Therapeutic by Product Category
  1.2.1 United States Exosome Diagnostic and Therapeutic Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Exosome Diagnostic and Therapeutic Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Instrument
  1.2.4 Reagent
  1.2.5 Software
1.3 United States Exosome Diagnostic and Therapeutic Market by Application/End Users
  1.3.1 United States Exosome Diagnostic and Therapeutic Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cancer Institute
  1.3.3 Hospital
  1.3.4 Diagnostic Center
  1.3.5 Others
1.4 United States Exosome Diagnostic and Therapeutic Market by Region
  1.4.1 United States Exosome Diagnostic and Therapeutic Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Exosome Diagnostic and Therapeutic Status and Prospect (2012-2022)
  1.4.3 Southwest Exosome Diagnostic and Therapeutic Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Exosome Diagnostic and Therapeutic Status and Prospect (2012-2022)
  1.4.5 New England Exosome Diagnostic and Therapeutic Status and Prospect (2012-2022)
  1.4.6 The South Exosome Diagnostic and Therapeutic Status and Prospect (2012-2022)
  1.4.7 The Midwest Exosome Diagnostic and Therapeutic Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Exosome Diagnostic and Therapeutic (2012-2022)
  1.5.1 United States Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2022)
  1.5.2 United States Exosome Diagnostic and Therapeutic Revenue and Growth Rate (2012-2022)

2 UNITED STATES EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Exosome Diagnostic and Therapeutic Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Exosome Diagnostic and Therapeutic Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Exosome Diagnostic and Therapeutic Average Price by Players/Suppliers (2012-2017)
2.4 United States Exosome Diagnostic and Therapeutic Market Competitive Situation and Trends
  2.4.1 United States Exosome Diagnostic and Therapeutic Market Concentration Rate
  2.4.2 United States Exosome Diagnostic and Therapeutic Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Exosome Diagnostic and Therapeutic Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES EXOSOME DIAGNOSTIC AND THERAPEUTIC SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Exosome Diagnostic and Therapeutic Sales and Market Share by Region (2012-2017)
3.2 United States Exosome Diagnostic and Therapeutic Revenue and Market Share by Region (2012-2017)
3.3 United States Exosome Diagnostic and Therapeutic Price by Region (2012-2017)

4 UNITED STATES EXOSOME DIAGNOSTIC AND THERAPEUTIC SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Exosome Diagnostic and Therapeutic Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Exosome Diagnostic and Therapeutic Revenue and Market Share by Type (2012-2017)
4.3 United States Exosome Diagnostic and Therapeutic Price by Type (2012-2017)
4.4 United States Exosome Diagnostic and Therapeutic Sales Growth Rate by Type (2012-2017)

5 UNITED STATES EXOSOME DIAGNOSTIC AND THERAPEUTIC SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Exosome Diagnostic and Therapeutic Sales and Market Share by Application (2012-2017)
5.2 United States Exosome Diagnostic and Therapeutic Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES EXOSOME DIAGNOSTIC AND THERAPEUTIC PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Aethlon Medical
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Exosome Diagnostic and Therapeutic Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Aethlon Medical Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Exosome Diagnostics
  6.2.2 Exosome Diagnostic and Therapeutic Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Exosome Diagnostics Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 NanoSomix
  6.3.2 Exosome Diagnostic and Therapeutic Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 NanoSomix Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Thermo Fisher Scientific
  6.4.2 Exosome Diagnostic and Therapeutic Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Thermo Fisher Scientific Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Malvern Instruments
  6.5.2 Exosome Diagnostic and Therapeutic Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Malvern Instruments Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 System Biosciences
  6.6.2 Exosome Diagnostic and Therapeutic Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 System Biosciences Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 NX Pharmagen
  6.7.2 Exosome Diagnostic and Therapeutic Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 NX Pharmagen Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Sistemic
  6.8.2 Exosome Diagnostic and Therapeutic Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sistemic Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Capricor Therapeutics
  6.9.2 Exosome Diagnostic and Therapeutic Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Capricor Therapeutics Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Exiqon
  6.10.2 Exosome Diagnostic and Therapeutic Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Exiqon Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 101BIO
6.12 AMS Biotechnology Limited
6.13 Therapeutic Solutions International
6.14 ReNeuron Group
6.15 Immune Therapy Holdings
6.16 ExoCyte Therapeutics
6.17 Cell Guidance Systems
6.18 BioRegenerative Sciences
6.19 Evomic Science
6.20 Norgen Biotek

7 EXOSOME DIAGNOSTIC AND THERAPEUTIC MANUFACTURING COST ANALYSIS

7.1 Exosome Diagnostic and Therapeutic Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Exosome Diagnostic and Therapeutic

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Exosome Diagnostic and Therapeutic Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Exosome Diagnostic and Therapeutic Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Exosome Diagnostic and Therapeutic Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Exosome Diagnostic and Therapeutic Sales Volume Forecast by Type (2017-2022)
11.3 United States Exosome Diagnostic and Therapeutic Sales Volume Forecast by Application (2017-2022)
11.4 United States Exosome Diagnostic and Therapeutic Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Exosome Diagnostic and Therapeutic
Figure United States Exosome Diagnostic and Therapeutic Market Size (K Units) by Type (2012-2022)
Figure United States Exosome Diagnostic and Therapeutic Sales Volume Market Share by Type (Product Category) in 2016
Figure Instrument Product Picture
Figure Reagent Product Picture
Figure Software Product Picture
Figure United States Exosome Diagnostic and Therapeutic Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Exosome Diagnostic and Therapeutic by Application in 2016
Figure Cancer Institute Examples
Table Key Downstream Customer in Cancer Institute
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Diagnostic Center Examples
Table Key Downstream Customer in Diagnostic Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Exosome Diagnostic and Therapeutic Market Size (Million USD) by Region (2012-2022)
Figure The West Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2022)
Figure United States Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Exosome Diagnostic and Therapeutic Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Exosome Diagnostic and Therapeutic Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Exosome Diagnostic and Therapeutic Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Exosome Diagnostic and Therapeutic Sales Share by Players/Suppliers
Figure 2017 United States Exosome Diagnostic and Therapeutic Sales Share by Players/Suppliers
Figure United States Exosome Diagnostic and Therapeutic Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Exosome Diagnostic and Therapeutic Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Exosome Diagnostic and Therapeutic Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Exosome Diagnostic and Therapeutic Revenue Share by Players/Suppliers
Figure 2017 United States Exosome Diagnostic and Therapeutic Revenue Share by Players/Suppliers
Table United States Market Exosome Diagnostic and Therapeutic Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Exosome Diagnostic and Therapeutic Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Exosome Diagnostic and Therapeutic Market Share of Top 3 Players/Suppliers
Figure United States Exosome Diagnostic and Therapeutic Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Exosome Diagnostic and Therapeutic Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Exosome Diagnostic and Therapeutic Product Category
Table United States Exosome Diagnostic and Therapeutic Sales (K Units) by Region (2012-2017)
Table United States Exosome Diagnostic and Therapeutic Sales Share by Region (2012-2017)
Figure United States Exosome Diagnostic and Therapeutic Sales Share by Region (2012-2017)
Figure United States Exosome Diagnostic and Therapeutic Sales Market Share by Region in 2016
Table United States Exosome Diagnostic and Therapeutic Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Exosome Diagnostic and Therapeutic Revenue Share by Region (2012-2017)
Figure United States Exosome Diagnostic and Therapeutic Revenue Market Share by Region (2012-2017)
Figure United States Exosome Diagnostic and Therapeutic Revenue Market Share by Region in 2016
Table United States Exosome Diagnostic and Therapeutic Price (USD/Unit) by Region (2012-2017)
Table United States Exosome Diagnostic and Therapeutic Sales (K Units) by Type (2012-2017)
Table United States Exosome Diagnostic and Therapeutic Sales Share by Type (2012-2017)
Figure United States Exosome Diagnostic and Therapeutic Sales Share by Type (2012-2017)
Figure United States Exosome Diagnostic and Therapeutic Sales Market Share by Type in 2016
Table United States Exosome Diagnostic and Therapeutic Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Exosome Diagnostic and Therapeutic Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Exosome Diagnostic and Therapeutic by Type (2012-2017)
Figure Revenue Market Share of Exosome Diagnostic and Therapeutic by Type in 2016
Table United States Exosome Diagnostic and Therapeutic Price (USD/Unit) by Types (2012-2017)
Figure United States Exosome Diagnostic and Therapeutic Sales Growth Rate by Type (2012-2017)
Table United States Exosome Diagnostic and Therapeutic Sales (K Units) by Application (2012-2017)
Table United States Exosome Diagnostic and Therapeutic Sales Market Share by Application (2012-2017)
Figure United States Exosome Diagnostic and Therapeutic Sales Market Share by Application (2012-2017)
Figure United States Exosome Diagnostic and Therapeutic Sales Market Share by Application in 2016
Table United States Exosome Diagnostic and Therapeutic Sales Growth Rate by Application (2012-2017)
Figure United States Exosome Diagnostic and Therapeutic Sales Growth Rate by Application (2012-2017)
Table Aethlon Medical Basic Information List
Table Aethlon Medical Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aethlon Medical Exosome Diagnostic and Therapeutic Sales Growth Rate (2012-2017)
Figure Aethlon Medical Exosome Diagnostic and Therapeutic Sales Market Share in United States (2012-2017)
Figure Aethlon Medical Exosome Diagnostic and Therapeutic Revenue Market Share in United States (2012-2017)
Table Exosome Diagnostics Basic Information List
Table Exosome Diagnostics Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Exosome Diagnostics Exosome Diagnostic and Therapeutic Sales Growth Rate (2012-2017)
Figure Exosome Diagnostics Exosome Diagnostic and Therapeutic Sales Market Share in United States (2012-2017)
Figure Exosome Diagnostics Exosome Diagnostic and Therapeutic Revenue Market Share in United States (2012-2017)
Table NanoSomix Basic Information List
Table NanoSomix Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure NanoSomix Exosome Diagnostic and Therapeutic Sales Growth Rate (2012-2017)
Figure NanoSomix Exosome Diagnostic and Therapeutic Sales Market Share in United States (2012-2017)
Figure NanoSomix Exosome Diagnostic and Therapeutic Revenue Market Share in United States (2012-2017)
Table Thermo Fisher Scientific Basic Information List
Table Thermo Fisher Scientific Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Exosome Diagnostic and Therapeutic Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Exosome Diagnostic and Therapeutic Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific Exosome Diagnostic and Therapeutic Revenue Market Share in United States (2012-2017)
Table Malvern Instruments Basic Information List
Table Malvern Instruments Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Malvern Instruments Exosome Diagnostic and Therapeutic Sales Growth Rate (2012-2017)
Figure Malvern Instruments Exosome Diagnostic and Therapeutic Sales Market Share in United States (2012-2017)
Figure Malvern Instruments Exosome Diagnostic and Therapeutic Revenue Market Share in United States (2012-2017)
Table System Biosciences Basic Information List
Table System Biosciences Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure System Biosciences Exosome Diagnostic and Therapeutic Sales Growth Rate (2012-2017)
Figure System Biosciences Exosome Diagnostic and Therapeutic Sales Market Share in United States (2012-2017)
Figure System Biosciences Exosome Diagnostic and Therapeutic Revenue Market Share in United States (2012-2017)
Table NX Pharmagen Basic Information List
Table NX Pharmagen Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure NX Pharmagen Exosome Diagnostic and Therapeutic Sales Growth Rate (2012-2017)
Figure NX Pharmagen Exosome Diagnostic and Therapeutic Sales Market Share in United States (2012-2017)
Figure NX Pharmagen Exosome Diagnostic and Therapeutic Revenue Market Share in United States (2012-2017)
Table Sistemic Basic Information List
Table Sistemic Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sistemic Exosome Diagnostic and Therapeutic Sales Growth Rate (2012-2017)
Figure Sistemic Exosome Diagnostic and Therapeutic Sales Market Share in United States (2012-2017)
Figure Sistemic Exosome Diagnostic and Therapeutic Revenue Market Share in United States (2012-2017)
Table Capricor Therapeutics Basic Information List
Table Capricor Therapeutics Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Capricor Therapeutics Exosome Diagnostic and Therapeutic Sales Growth Rate (2012-2017)
Figure Capricor Therapeutics Exosome Diagnostic and Therapeutic Sales Market Share in United States (2012-2017)
Figure Capricor Therapeutics Exosome Diagnostic and Therapeutic Revenue Market Share in United States (2012-2017)
Table Exiqon Basic Information List
Table Exiqon Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Exiqon Exosome Diagnostic and Therapeutic Sales Growth Rate (2012-2017)
Figure Exiqon Exosome Diagnostic and Therapeutic Sales Market Share in United States (2012-2017)
Figure Exiqon Exosome Diagnostic and Therapeutic Revenue Market Share in United States (2012-2017)
Table 101BIO Basic Information List
Table AMS Biotechnology Limited Basic Information List
Table Therapeutic Solutions International Basic Information List
Table ReNeuron Group Basic Information List
Table Immune Therapy Holdings Basic Information List
Table ExoCyte Therapeutics Basic Information List
Table Cell Guidance Systems Basic Information List
Table BioRegenerative Sciences Basic Information List
Table Evomic Science Basic Information List
Table Norgen Biotek Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Exosome Diagnostic and Therapeutic
Figure Manufacturing Process Analysis of Exosome Diagnostic and Therapeutic
Figure Exosome Diagnostic and Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of Exosome Diagnostic and Therapeutic Major Players/Suppliers in 2016
Table Major Buyers of Exosome Diagnostic and Therapeutic
Table Distributors/Traders List
Figure United States Exosome Diagnostic and Therapeutic Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Exosome Diagnostic and Therapeutic Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Exosome Diagnostic and Therapeutic Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Exosome Diagnostic and Therapeutic Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Exosome Diagnostic and Therapeutic Sales Volume (K Units) Forecast by Type in 2022
Table United States Exosome Diagnostic and Therapeutic Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Exosome Diagnostic and Therapeutic Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Exosome Diagnostic and Therapeutic Sales Volume (K Units) Forecast by Application in 2022
Table United States Exosome Diagnostic and Therapeutic Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Exosome Diagnostic and Therapeutic Sales Volume Share Forecast by Region (2017-2022)
Figure United States Exosome Diagnostic and Therapeutic Sales Volume Share Forecast by Region (2017-2022)
Figure United States Exosome Diagnostic and Therapeutic Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories